Navigation Links
Connecticut Technology Council Honors UHY LLP Tech Top 40 Winners
Date:11/6/2008

Announces Category Winners and Names Ticket Software LLC as State's Fastest Growing Technology Company

HARTFORD, Conn., Nov. 6 /PRNewswire/ -- The Connecticut Technology Council and the accounting firm UHY LLP feted the 40 fastest growing technology companies in Connecticut last night at the Chevrolet Theater in Wallingford. The list of winning companies, which had been released last month and included such well known brands as Priceline.com and Jupitermedia, also included companies gaining prominence in their technology markets such as FuelCell Energy and Defibtech.

The evening's biggest announcement came at the end of the awards program when Ticket Software LLC was named Connecticut's fastest growing technology company in 2008. It grew at the impressive rate of 4828% over the last four years. The Vernon company, Connecticut's answer to StubHub, has been adding staff and growing revenue at a rapid pace.

The Council also announced the six companies whose revenue put them at the top in their technology category:

In Advanced Manufacturing, Pelham Sloane, which makes sleek, thin computers primarily for the healthcare, hospitality and retail industries, emerged as the winner. Stamford's Clean Diesel Technologies, the "green company" winner, captured the prize in the Energy/Environmental Technologies category. In Life Sciences the winner was Cheshire's Alexion Pharmaceuticals, which brought its successful first drug candidate, Soliris, to both the American and European markets in 2007. In the New Media/Internet/Telecom technology category it was New London's JobTarget LLC capturing the prize for fastest revenue growth. JobTarget builds custom-built, private-label "Career Centers" or online job sites for trade associations, government and other organizations. MTM Technologies, Inc. of Stamford was the winner in the IT Services category, while the aforementioned Ticket Software won in the Software technology vertical.

The list of w
'/>"/>

SOURCE The Connecticut Technology Council
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Connecticut BioBus Travels to State Capitol on April 24 for Tours and Experiments with Visiting Students
2. Connecticut Technology Council to Recognize Fast Growing Technology Companies
3. Connecticut State Medical Society and Genomas Co-Sponsor Forum on DNA-Guided Medicine and the Path to Personalized Health Care
4. Connecticut Technology Council Announces UHY LLP Tech Top 40 Winners
5. Connecticuts Universities Team Up to Host 2009 Stem Cell Symposium
6. Solos Endoscopy, Inc. Receives Purchase Order from Connecticut Hospital
7. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
8. Novel Technology Breaks Through Cancer Pain
9. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
10. Advanced Cell Technology Announces Proposed Financing
11. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
Post Your Comments:
*Name:
*Comment:
*Email:
Other Biology Technology:Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases 2Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases 3Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases 4Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases 5Genmab Discloses Target and Development Plans for HuMax-Inflam 2Genmab Discloses Target and Development Plans for HuMax-Inflam 3New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA 2New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA 3New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA 4